BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3275 related articles for article (PubMed ID: 7496159)

  • 1. Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas.
    Vidal MJ; Loganzo F; de Oliveira AR; Hayward NK; Albino AP
    Melanoma Res; 1995 Aug; 5(4):243-50. PubMed ID: 7496159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.
    Jiang H; Lin J; Su ZZ; Herlyn M; Kerbel RS; Weissman BE; Welch DR; Fisher PB
    Oncogene; 1995 May; 10(9):1855-64. PubMed ID: 7753561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
    Shi Y; Zou M; Farid NR; al-Sedairy ST
    Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.
    Wang Y; Becker D
    Oncogene; 1996 Mar; 12(5):1069-75. PubMed ID: 8649798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and sequence analysis of the p21(WAF1/CIP1) gene in renal cancers.
    Papandreou CN; Bogenrieder T; Loganzo F; Albino AP; Nanus DM
    Urology; 1997 Mar; 49(3):481-6. PubMed ID: 9123723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WAF1/p21 regulates proliferation, but does not mediate p53-dependent apoptosis in urothelial carcinoma cell lines.
    Makri D; Schulz WA; Grimm M; Clasen S; Bojar H; Schmitz-Dräger BJ
    Int J Oncol; 1998 Mar; 12(3):621-8. PubMed ID: 9472102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.
    Akashi M; Osawa Y; Koeffler HP; Hachiya M
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):607-16. PubMed ID: 9895308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 expression in CMV-infected cells: association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2.
    García JF; Piris MA; Lloret E; Orradre JL; Murillo PG; Martínez JC
    Histopathology; 1997 Feb; 30(2):120-5. PubMed ID: 9067734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of WAF1 mutations in a variety of human malignancies.
    Shiohara M; el-Deiry WS; Wada M; Nakamaki T; Takeuchi S; Yang R; Chen DL; Vogelstein B; Koeffler HP
    Blood; 1994 Dec; 84(11):3781-4. PubMed ID: 7949134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms.
    Wong NA; Mayer NJ; Anderson CE; McKenzie HC; Morris RG; Diebold J; Mayr D; Brock IW; Royds JA; Gilmour HM; Harrison DJ
    Hum Pathol; 2003 Jun; 34(6):580-8. PubMed ID: 12827612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
    Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
    Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox-mediated regulation of p21(waf1/cip1) expression involves a post-transcriptional mechanism and activation of the mitogen-activated protein kinase pathway.
    Esposito F; Cuccovillo F; Vanoni M; Cimino F; Anderson CW; Appella E; Russo T
    Eur J Biochem; 1997 May; 245(3):730-7. PubMed ID: 9183012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis-inducing levels of UV radiation and proteasome inhibitors produce opposite effects on p21(WAF1) in human melanoma cells.
    Rieber M; Strasberg Rieber M
    Int J Cancer; 2000 May; 86(4):462-7. PubMed ID: 10797256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon regulates expression of mda-6/WAF1/CIP1 and cyclin-dependent kinases independently from p53 in B16 murine melanoma cells.
    Arany I; Fleischmann CM; Tyring SK; Fleischmann WR
    Biochem Biophys Res Commun; 1997 Apr; 233(3):678-80. PubMed ID: 9168913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced messenger RNA expression level of p21 CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation.
    Matsushita K; Kobayashi S; Kato M; Itoh Y; Okuyama K; Sakiyama S; Isono K
    Int J Cancer; 1996 Aug; 69(4):259-64. PubMed ID: 8797864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 164.